Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Angelica C. Kottkamp"'
Autor:
Kirsten E. Lyke, Robert L. Atmar, Clara Dominguez Islas, Christine M. Posavad, Meagan E. Deming, Angela R. Branche, Christine Johnston, Hana M. El Sahly, Srilatha Edupuganti, Mark J. Mulligan, Lisa A. Jackson, Richard E. Rupp, Christina A. Rostad, Rhea N. Coler, Martín Bäcker, Angelica C. Kottkamp, Tara M. Babu, David Dobrzynski, Judith M. Martin, Rebecca C. Brady, Robert W. Frenck, Kumaravel Rajakumar, Karen Kotloff, Nadine Rouphael, Daniel Szydlo, Rahul PaulChoudhury, Janet I. Archer, Sonja Crandon, Brian Ingersoll, Amanda Eaton, Elizabeth R. Brown, M. Juliana McElrath, Kathleen M. Neuzil, David S. Stephens, Diane J. Post, Bob C. Lin, Leonid Serebryannyy, John H. Beigel, David C. Montefiori, Paul C. Roberts, the DMID 21-0012 Study Group
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-10 (2023)
Abstract As part of a multicenter study evaluating homologous and heterologous COVID-19 booster vaccines, we assessed the magnitude, breadth, and short-term durability of binding and pseudovirus-neutralizing antibody (PsVNA) responses following a sin
Externí odkaz:
https://doaj.org/article/25f04fdb644f4573b07bd819954db49f
Autor:
Angela R Branche, Nadine G Rouphael, Cecilia Losada, Lindsey R Baden, Evan J Anderson, Anne F Luetkemeyer, David J Diemert, Patricia L Winokur, Rachel M Presti, Angelica C Kottkamp, Ann R Falsey, Sharon E Frey, Richard Rupp, Martín Bäcker, Richard M Novak, Emmanuel B Walter, Lisa A Jackson, Susan J Little, Lilly C Immergluck, Siham M Mahgoub, Jennifer A Whitaker, Tara M Babu, Paul A Goepfert, Dahlene N Fusco, Robert L Atmar, Christine M Posavad, Antonia Netzl, Derek J Smith, Kalyani Telu, Jinjian Mu, Mat Makowski, Mamodikoe K Makhene, Sonja Crandon, David C Montefiori, Paul C Roberts, John H Beigel
Publikováno v:
Clinical Infectious Diseases.
In a randomized clinical trial, we compare early neutralizing antibody responses after boosting with bivalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines based on either BA.1 or BA.4/BA.5 Omicron spike p
Autor:
Angela R. Branche, Nadine G. Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer, David J. Diemert, Patricia L. Winokur, Rachel M. Presti, Angelica C. Kottkamp, Ann R. Falsey, Sharon E. Frey, Richard Rupp, Martín Bäcker, Richard M. Novak, Emmanuel B. Walter, Lisa A. Jackson, Susan J. Little, Lilly C. Immergluck, Siham M. Mahgoub, Jennifer A. Whitaker, Tara M. Babu, Paul A. Goepfert, Dahlene N. Fusco, Robert L. Atmar, Christine M. Posavad, Antonia Netzl, Derek J. Smith, Kalyani Telu, Jinjian Mu, Mat Makowski, Mamodikoe K. Makhene, Sonja Crandon, David C. Montefiori, Paul C. Roberts, John H. Beigel
Publikováno v:
medRxiv
In a randomized clinical trial, we compare early neutralizing antibody responses after boosting with bivalent SARS-CoV-2 mRNA vaccines based on either BA.1 or BA.4/BA.5 Omicron spike protein combined with wildtype spike. Responses against SARS-CoV-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b88c08987da7ee3b0952c4735903bfb8
https://europepmc.org/articles/PMC10081431/
https://europepmc.org/articles/PMC10081431/
Autor:
Anna Bershteyn, Angela M Dahl, Tracy Q Dong, Meagan E Deming, Connie L Celum, Helen Y Chu, Angelica C Kottkamp, Alexander L Greninger, Risa M Hoffman, Keith R Jerome, Christine M Johnston, Patricia J Kissinger, Raphael J Landovitz, Miriam K Laufer, Alfred Luk, Kathleen M Neuzil, Michael K Paasche-Orlow, Robert A Pitts, Mark D Schwartz, Helen C Stankiewicz Karita, Lorna E Thorpe, Anna Wald, Crystal Y Zheng, Mark H Wener, Ruanne V Barnabas, Elizabeth R Brown
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 75, iss 1
Coronavirus disease 2019 symptom definitions rarely include symptom severity. We collected daily nasal swab samples and symptom diaries from contacts of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) case patients. Requiring ≥1 modera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840cdd112fb153cf6cc8186d677614bd
https://escholarship.org/uc/item/7c45r16h
https://escholarship.org/uc/item/7c45r16h
Autor:
Erin M, Scherer, Martin, Backer, Karen, Carvajal, Lara, Danziger-Isakov, Sharon, Frey, Leigh M, Howard, Felicia Scaggs, Huang, Angelica C, Kottkamp, Tara, Reid, Maria C, Rodriguez-Barradas, Helen C Stankiewicz, Karita, Zheyi, Teoh, Anna, Wald, Jennifer, Whitaker, Zanthia, Wiley, Igho, Ofotokun, Kathryn M, Edwards
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
The COVID-19 pandemic and associated increase in family care responsibilities resulted in unsustainable personal and professional workloads for Infectious Diseases (ID) faculty on the front lines. This was especially true for early-stage faculty (ESF
Autor:
Robert L, Atmar, Kirsten E, Lyke, Meagan E, Deming, Lisa A, Jackson, Angela R, Branche, Hana M, El Sahly, Christina A, Rostad, Judith M, Martin, Christine, Johnston, Richard E, Rupp, Mark J, Mulligan, Rebecca C, Brady, Robert W, Frenck, Martín, Bäcker, Angelica C, Kottkamp, Tara M, Babu, Kumaravel, Rajakumar, Srilatha, Edupuganti, David, Dobrzynski, Rhea N, Coler, Christine M, Posavad, Janet I, Archer, Sonja, Crandon, Seema U, Nayak, Daniel, Szydlo, Jillian A, Zemanek, Clara P, Dominguez Islas, Elizabeth R, Brown, Mehul S, Suthar, M Juliana, McElrath, Adrian B, McDermott, Sarah E, O'Connell, David C, Montefiori, Amanda, Eaton, Kathleen M, Neuzil, David S, Stephens, Paul C, Roberts, John H, Beigel, Todd, Haight
Publikováno v:
The New England journal of medicine. 386(11)
Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are highly effective, breakthrough infections are occurring. Data are needed on the serial use of homologous b
Autor:
Meagan E Deming, Tracy Q Dong, Vaidehi Agrawal, Margaret G Mills, Meei Li W Huang, Alexander L Greninger, Keith R Jerome, Mark H Wener, Michael K Paasche-Orlow, Patricia Kissinger, Alfred Luk, Risa M Hoffman, Jenell Stewart, Angelica C Kottkamp, Anna Bershteyn, Helen Y Chu, Helen C Stankiewicz Karita, Christine M Johnston, Anna Wald, Ruanne Barnabas, Elizabeth R Brown, Kathleen M Neuzil
Publikováno v:
The Journal of infectious diseases. 226(5)
While detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by diagnostic reverse-transcription polymerase chain reaction (RT-PCR) is highly sensitive for viral RNA, the nucleic acid amplification of subgenomic RNAs (sgRNAs) that
Autor:
Robert L, Atmar, Kirsten E, Lyke, Meagan E, Deming, Lisa A, Jackson, Angela R, Branche, Hana M, El Sahly, Christina A, Rostad, Judith M, Martin, Christine, Johnston, Richard E, Rupp, Mark J, Mulligan, Rebecca C, Brady, Robert W, Frenck, Martín, Bäcker, Angelica C, Kottkamp, Tara M, Babu, Kumaravel, Rajakumar, Srilatha, Edupuganti, David, Dobryzynski, Christine M, Posavad, Janet I, Archer, Sonja, Crandon, Seema U, Nayak, Daniel, Szydlo, Jillian, Zemanek, Clara P Dominguez, Islas, Elizabeth R, Brown, Mehul S, Suthar, M Juliana, McElrath, Adrian B, McDermott, Sarah E, O'Connell, David C, Montefiori, Amanda, Eaton, Kathleen M, Neuzil, David S, Stephens, Paul C, Roberts, John H, Beigel
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 2
article-version (status) pre
article-version (number) 2
BackgroundWhile Coronavirus disease 2019 (Covid-19) vaccines are highly effective, breakthrough infections are occurring. Booster vaccinations have recently received emergency use authorization (EUA) for certain populations but are restricted to homo
Autor:
Kirsten E. Lyke, Angela R. Branche, Hana M. El Sahly, Christina A. Rostad, Judith M. Martin, Christine Johnston, Richard E. Rupp, Mark J. Mulligan, Rebecca C. Brady, Robert W. Frenck, Martín Bäcker, Robert L. Atmar, Angelica C. Kottkamp, Tara M. Babu, Kumaravel Rajakumar, Srilatha Edupuganti, David Dobrzynski, Rhea N. Coler, Janet I. Archer, Sonja Crandon, Jillian A. Zemanek, Elizabeth R. Brown, Clara Dominguez Islas, Kathleen M. Neuzil, David S. Stephens, Diane J. Post, Seema U. Nayak, Mehul S. Suthar, Paul C. Roberts, John H. Beigel, David C. Montefiori, Jennifer S. Husson, Angie Price, Christine M. Posavad, Jennifer A. Whitaker, Wendy A. Keitel, Ann R. Falsey, Ian Shannon, Daniel Graciaa, Nadine Rouphael, Evan J. Anderson, Satoshi Kamidani, Gysella B. Muniz, Sonika Bhatnagar, Daniel Szydlo, Anna Wald, Megan Berman, Laura Porterfield, Amber Stanford, Jennifer Lee Dong, Steven E. Carsons, Diana Badillo, Susan Parker, Michelle Dickey, Sasha E. Larsen, Rahul Paul Chourdhury, John Hural, Brian Ingersoll, Marina Lee, Lilin Lai, Katharine Floyd, Madison Ellis, Kathryn M. Moore, Kelly Manning, Stephanie L. Foster, Mit Patel, Meagan E. Deming, Amanda Eaton, Lisa A. Jackson
Publikováno v:
ORCID
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to generate protective immunity. We assess the magnitude and short-term
Publikováno v:
Open Forum Infectious Diseases. 2023 Supplement, Vol. 10, pS1-S1274. 3913p.